KOREA PHARMA Co., Ltd. (KOSDAQ: A032300)
Health Care · Pharmaceuticals · KR
₩8,570.00
-1.72% today · -37.7% 1Y
KOREA PHARMA Co., Ltd. (KOSDAQ: A032300) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $69.53M.
Over the last twelve months the share price has lost 37.7%, trading between 6.35K and 14.95K.
Tweenvest scores KOREA PHARMA Co., Ltd. across four factors: quality 75/100, value 66/100. Its strongest factor is quality.
A032300 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $69.53M
- Revenue (TTM)
- $60.66M
- P/E
- —
- EPS
- -70.21
- Dividend yield
- —
- Beta (5Y)
- 0.67
- 52-week high
- ₩14,950.00
- 52-week low
- ₩6,350.00
- Avg volume (3M)
- —
- Shares outstanding
- 10.91M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Wanbury LimitedBSE: 524212 | $70.71M | Rs195.85 | -1.58% |
| DongKoo Bio & Pharma Co., Ltd.KOSDAQ: A006620 | $70.70M | ₩3,515.00 | -0.14% |
| Verrica Pharmaceuticals Inc.NasdaqCM: VRCA | $70.60M | $4.08 | -0.73% |
| Poolbeg Pharma PLCAIM: POLB | $69.71M | £0.07 | -3.90% |
| WITHUS PHARMACEUTICAL Co.,LTD.KOSDAQ: A330350 | $69.12M | ₩7,040.00 | -2.90% |
| NeOnc Technologies Holdings, Inc.NasdaqGM: NTHI | $69.10M | $2.90 | +4.32% |
| Syngen Biotech Co.,Ltd.TPEX: 8279 | $68.57M | NT$80.90 | +1.76% |
| Y.S.P. Southeast Asia Holding BerhadKLSE: YSPSAH | $68.04M | RM1.96 | +1.55% |
Figures last refreshed Oct 11, 2026.